Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer

Recruiting now

Conditions studied: Breast Cancer

In brief

The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.

Key facts

Study ID

NCT06378944

Run by

Omphis Foundation

People needed

15000

Starts

2024-01-01

Expected to finish

2029-01-01

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients >18 years of age with breast cancer who are candidates for sentinel lymph node detection will be included.
• N0 patients or patients who have undergone target axillary detection with good response

You may not qualify if…

• Lymphadenectomy

Where it is running

• Sandra Lopez Gordo — Cerdanyola del Vallès, Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.